PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based ChemotherapySharlene Gill, Malcolm J. Moore, Sukhbinder Dhesy‐Thind et al.|Journal of Clinical Oncology|2016Cited by 291
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trialGeorg A. Bjarnason, Naveen S. Basappa, Jennifer J. Knox et al.|European Journal of Cancer|2019Cited by 28
Developing a Blood Cell‐Based Diagnostic Test for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Peripheral Blood Mononuclear CellsJiabao Xu, Karl Morten, Tiffany Lodge et al.|Advanced Science|2023Cited by 23
Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer.Georg A. Bjarnason, Naveen S. Basappa, Jennifer J. Knox et al.|Journal of Clinical Oncology|2017Cited by 7
A phase II multicenter study of the efficacy and safety of sunitinib given on an individualized schedule as first-line therapy for metastatic renal cell cancer.Georg A. Bjarnason, J. A. Miller, Naveen S. Basappa et al.|Journal of Clinical Oncology|2013Cited by 5